UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046361
Receipt number R000052900
Scientific Title A randomized control trial of adenoma detection rate in artificial intelligence-assisted colonoscopy using linked color imaging
Date of disclosure of the study information 2021/12/13
Last modified on 2024/12/15 22:28:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized control trial of adenoma detection rate in artificial intelligence-assisted colonoscopy using linked color imaging

Acronym

ADR by AI in LCI-colonoscopy

Scientific Title

A randomized control trial of adenoma detection rate in artificial intelligence-assisted colonoscopy using linked color imaging

Scientific Title:Acronym

ADR by AI in LCI-colonoscopy

Region

Japan


Condition

Condition

colonic adenoma

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to analyze of efficacy of artificial intelligence to adenoma detection rate in colonoscopy using linked color imaging

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

adenoma detection rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

artificial intelligence

Interventions/Control_2

no artificial intelligence

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with positive occult blood test, follow-up of colonic polyp or abdominal symptom

Key exclusion criteria

no preparation
ileus, stenosis, fistula, history of colonic surgery, IBD, diverticulitis
alcoholism
hyperthyroidosis
severe heart failure, liver disease or renal dysfunction
pregnancy

Target sample size

800


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Imaeda

Organization

Saitama Medical University Hospital

Division name

Department of Gastroenterology

Zip code

350-0495

Address

Morohongo 38, Moroyama-machi, Iruma-gun, Saitama

TEL

0492761667

Email

imaedahi@yahoo.co.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Imaeda

Organization

Saitama Medical University Hospital

Division name

Department of Gastroenterology

Zip code

350-0495

Address

Morohongo 38, Moroyama-machi, Iruma-gun, Saitama

TEL

0492761667

Homepage URL


Email

imaedahi@yahoo.co.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University Hospital

Address

Morohongo 38, Moroyama-machi, Iruma-gun, Saitama

Tel

0492761111

Email

hirb@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

800

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 12 Month 13 Day

Date of IRB

2022 Year 02 Month 07 Day

Anticipated trial start date

2022 Year 02 Month 10 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 13 Day

Last modified on

2024 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052900